Intra-articular Platelet Rich Plasma vs Corticosteroid in Treatment of Knee Osteoarthritis Patients
Osteoarthritis Knee, Corticosteroid, Platelet Rich Plasma
About this trial
This is an interventional treatment trial for Osteoarthritis Knee
Eligibility Criteria
Inclusion Criteria: Patients 40-70 years of age suffering from knee OA with Kellgren Lawrence grade II or III on standing antero-posterior and lateral knee radiographs. Patients diagnosed according to ACR classification criteria. Exclusion Criteria: Systemic diseases as Patients having diabetes mellitus,Cardiovascular diseases or coagulopathies. Those receiving treatment with anticoagulant , anti_platelet medications or systemic corticosteroid 10 days before injection or recent use of NSAIDs. Pregnant and breast feeding females. Patients have hemoglobin values <10 g/dl or platelet values<150,000/ml.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
OA group injected by corticosteroid
OA group injected by Platelet Rich Plasma
Group l include 50 patients who will be injected with one intra_articular injection of 2 ml of methylprednisolone acetate 40 mg/ml mixed with 2ml of lidocaine
Group lI include 50 patients who will be injected with a single 5 ml intra_articular injection of PRP prepared in our hospital